Quipt Home Medical Corp. (NASDAQ:QIPT) Short Interest Update

Quipt Home Medical Corp. (NASDAQ:QIPT) was the recipient of a significant increase in short interest in December. As of December 15th, there was short interest totalling 1,050,000 shares, an increase of 19.3% from the November 30th total of 880,100 shares. Based on an average daily volume of 167,800 shares, the short-interest ratio is presently 6.3 days. Currently, 2.7% of the shares of the stock are sold short.

Quipt Home Medical Price Performance

Shares of NASDAQ QIPT traded up $0.25 during trading on Tuesday, hitting $3.05. The company had a trading volume of 543,839 shares, compared to its average volume of 196,083. Quipt Home Medical has a 52 week low of $2.30 and a 52 week high of $5.26. The business’s 50-day moving average is $2.63 and its 200 day moving average is $2.91. The company has a market cap of $131.43 million, a P/E ratio of -27.73 and a beta of 0.62. The company has a debt-to-equity ratio of 0.66, a quick ratio of 0.77 and a current ratio of 1.11.

Quipt Home Medical (NASDAQ:QIPT) last announced its earnings results on Monday, December 16th. The company reported ($0.07) EPS for the quarter, missing the consensus estimate of $0.01 by ($0.08). Quipt Home Medical had a negative net margin of 1.95% and a negative return on equity of 4.51%. Equities research analysts predict that Quipt Home Medical will post -0.1 earnings per share for the current fiscal year.

Insider Buying and Selling

In other Quipt Home Medical news, VP Patrick Dennis Gamble acquired 17,000 shares of the stock in a transaction dated Thursday, December 26th. The shares were bought at an average price of $2.45 per share, with a total value of $41,650.00. Following the purchase, the vice president now directly owns 40,057 shares of the company’s stock, valued at approximately $98,139.65. This trade represents a 73.73 % increase in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available through this link. 4.20% of the stock is owned by corporate insiders.

Institutional Inflows and Outflows

Several hedge funds and other institutional investors have recently made changes to their positions in QIPT. Forager Capital Management LLC boosted its stake in Quipt Home Medical by 77.7% in the 3rd quarter. Forager Capital Management LLC now owns 4,192,562 shares of the company’s stock worth $12,200,000 after purchasing an additional 1,833,590 shares during the period. Royce & Associates LP raised its position in Quipt Home Medical by 15.8% during the third quarter. Royce & Associates LP now owns 1,768,789 shares of the company’s stock valued at $5,165,000 after buying an additional 240,980 shares during the period. Verition Fund Management LLC raised its position in Quipt Home Medical by 207.5% during the third quarter. Verition Fund Management LLC now owns 78,950 shares of the company’s stock valued at $231,000 after buying an additional 53,275 shares during the period. Rhumbline Advisers lifted its stake in Quipt Home Medical by 21.0% in the 2nd quarter. Rhumbline Advisers now owns 49,276 shares of the company’s stock worth $159,000 after acquiring an additional 8,541 shares in the last quarter. Finally, Bank of New York Mellon Corp boosted its position in Quipt Home Medical by 32.8% during the 2nd quarter. Bank of New York Mellon Corp now owns 129,738 shares of the company’s stock worth $418,000 after acquiring an additional 32,073 shares during the period. 42.85% of the stock is currently owned by institutional investors and hedge funds.

Quipt Home Medical Company Profile

Quipt Home Medical Corp., through its subsidiaries, engages in the provision of durable and home medical equipment and supplies in the United States. The company offers nebulizers, oxygen concentrators, and CPAP and BiPAP units; traditional and non-traditional durable medical respiratory equipment and services; non-invasive ventilation equipment, supplies, and services; and engages in the rental of medical equipment.